Looking ahead, the pace of IPOs could likely continue with financial offerings playing a big role via the $4 billion IPO filed recently from private equity manager The Blackstone Group. Meanwhile, three fresh IPOs emerged late Friday for their stock market debuts over the next few months. Amicus Therapeutics filed to raise up to $86 million in an IPO with underwriters Morgan Stanley and Merrill Lynch.
The Cranbury, N.J. clinical-stage biopharmaceutical company plans to trade on the Nasdaq under the symbol FOLD.
Data Domain Inc. filed to raise up to $100 million in an IPO with Goldman Sachs and Morgan Stanley. The Santa Clara, Calif.
-based seller of disk-based backup technology and network-based disaster recovery systems plans to trade on the Nasdaq under the symbol DDUP. Ireleand-based Merrion Pharmaceuticals Ltd. filed to raise up to $46 million in an IPO of American depositary shares with underwriter Punk Ziegel.
The company plans to trade on the Nasdaq under the symbol MERR. 